The results showed that the expression trends of PES1, CANX, SUMF2 and DCXR were consistent with the above predictions, especially SUMF2, which was not only reduced in T2DM and COPD patients, but also significantly reduced in patients with comorbidities compared with healthy controls. The gene discussed is PES1; the disease is type 2 diabetes mellitus.